Skip to content
Open access

(Elastography) E-BI-RADS: A Novel Classification System for Breast Elastography to Enable Safe Biopsy De-escalation.

Nov 2026 · Investigative Radiology · 0 citations · 18 references
Medicine

Abstract

Objectives

Determining the probability of malignancy of a breast lesion allows for the appropriate triage of follow-up. Although BI-RADS provides standardized risk stratification for mammography, ultrasound, and magnetic resonance imaging, no equivalent classification system exists for breast elastography. The aim of this study was to develop and evaluate a data-driven E-BI-RADS classification for breast elastography and to compare its diagnostic performance with B-mode BI-RADS.

Materials And Methods

In this retrospective study, consecutive patients undergoing breast imaging with available B-mode ultrasound, shear-wave elastography (SWE), and strain elastography (10L4 transducer, Siemens ACUSON Sequoia) from 06/2023 to 12/2025 were included. A multivariable logistic regression model combining SWE velocity and elastography-to-B-mode lesion size (E/B) ratio was used to estimate malignancy probability, followed by Platt recalibration. Data-driven probability cutoffs were derived to define E-BI-RADS categories aligned with the BI-RADS concept. (E-)BI-RADS categories 4 and 5 were considered an indication for biopsy. Histopathologic evaluation or imaging follow-up served as the reference standard.

Results

The cohort comprised 344 breast lesions in 337 patients, including 224 (65.1%) malignant and 120 (34.9%) benign lesions. B-mode BI-RADS achieved a sensitivity of 98.6% (221/224) and a specificity of 34.2% (41/120). E-BI-RADS demonstrated malignancy rates of 0.0% in E-BI-RADS 2 (0/71); 5.3% in E-BI-RADS 3 (1/19); 85.2% in E-BI-RADS 4 (155/182); and 94.4% in E-BI-RADS 5 (68/70). E-BI-RADS achieved a sensitivity of 99.6% (223/224) and a specificity of 74.2% (89/120). The single false-negative case was a 31 mm B-cell lymphoma, classified as E-BI-RADS 3, with a shear-wave velocity of 4.4 m/s and an E/B ratio of 0.9. Decision-curve analysis demonstrates that E-BI-RADS achieves higher net benefit than SWE-based and B-mode BI-RADS strategies.

Discussion

E-BI-RADS provides the first standardized, BI-RADS-like classification system for breast elastography and enables safe biopsy de-escalation with excellent sensitivity and improved specificity compared with existing approaches.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.